Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Creso Pharma introduces cannaDOL in Europe, for join and muscle pain
March 15, 2018 Off

Creso Pharma introduces cannaDOL in Europe, for join and muscle pain

By Dino Mustafić

Creso Pharma will introduce the cannaDOL product range with an oral Cannabidiol-(CBD)-based nutraceutical and first-in-class CBD-based functional cosmetics across Europe…

Hikma posts operating loss of $747 million, as it takes an impairment related to the West-Ward Columbus business
March 14, 2018 Off

Hikma posts operating loss of $747 million, as it takes an impairment related to the West-Ward Columbus business

By Dino Mustafić

Hikma Pharmaceutical has delivered a solid performance in 2017 showing the benefit of our diversified business model, Said Darwazah, Executive Chairman…

ARC’s in combination with chemotherapy could be exciting development opportunity for AMLeukemia patients, MC of Wisconsin cleared to study Actimab-A+CLAG-M
March 13, 2018 Off

ARC’s in combination with chemotherapy could be exciting development opportunity for AMLeukemia patients, MC of Wisconsin cleared to study Actimab-A+CLAG-M

By Dino Mustafić

A Phase 1 trial of Actimab-A in combination with CLAG-M for relapsed or refractory Acute Myeloid Leukemia (AML) patients, will be…

Pacific Biosciences patents method for single molecule sequencing of concatemers
March 13, 2018 Off

Pacific Biosciences patents method for single molecule sequencing of concatemers

By Dino Mustafić

Pacific Biosciences of California has patented its methods for single molecule sequencing of concatemers having complementary sense and antisense regions…

Vortex, BioView together working on collecting CTCs from blood samples to give deeper insights into cancer biology
March 13, 2018 Off

Vortex, BioView together working on collecting CTCs from blood samples to give deeper insights into cancer biology

By Dino Mustafić

Vortex BioSciences and Israeli provider of automated cell imaging and analysis solutions, BioView , will work on collecting intact circulating tumour cells…

Hemogenyx expands deal with US biotech company for quarter million USD
March 13, 2018 Off

Hemogenyx expands deal with US biotech company for quarter million USD

By Dino Mustafić

Hemogenyx Pharmaceuticals has ensured a continuation of a pact with a major US biotechnology company for filing of a provisional patent…

Novartis reshuffles senior leadership chairs, splits operations into technical operations and business services
March 12, 2018 Off

Novartis reshuffles senior leadership chairs, splits operations into technical operations and business services

By Dino Mustafić

Novartis has made several changes as it added several figures in the team starting April, while its Operations president, André…

Portola Pharmaceuticals appoints Moriarty as legal officer
March 12, 2018 Off

Portola Pharmaceuticals appoints Moriarty as legal officer

By Dino Mustafić

Portola Pharmaceuticals has appointed John B. Moriarty, J.D., as executive vice president and general counsel, who will report to William…

How monoclonal antibodies can fight emerging infectious diseases?
March 9, 2018 Off

How monoclonal antibodies can fight emerging infectious diseases?

By Dino Mustafić

Monoclonal antibodies (mAbs) — preparations of a specific type of antibody designed to bind to a single target — have…

GSK, Innoviva get EC’s label update, once daily Relvar Ellipta as good as as twice-daily ICS/LABA for patients with asthma
March 8, 2018 Off

GSK, Innoviva get EC’s label update, once daily Relvar Ellipta as good as as twice-daily ICS/LABA for patients with asthma

By Dino Mustafić

The European Commission has approved a label update for the use of GlaxoSmithKline and Innoviva’s Relvar Ellipta, an inhaled corticosteroid (ICS) / long-acting β2-agonist (LABA)…

Posts pagination

Previous 1 … 3,397 3,398 3,399 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine